glp-1 neuropathy The science of safety: adverse effects of receptor agonists as glucose-lowering and obesity medications GLP-1 Receptor Agonists as Treatments

Incretin action plays a large role on post-prandial secretion of insulin, and may account for up to 70% of hormone release (6)

This can influence several cellular functions, including insulin secretion in pancreatic islet cells, as depicted in the schematic

J Interferon Cytokine Res

GLP-1 RAs have transformed the landscape of diabetes care by providing not only effective glycemic control but also substantial cardiovascular (CV) protection and significant weight loss [17,18]

PRIN: PROGETTI DI RICERCA DI RILEVANTE INTERESSE NAZIONALE / Bando 2022 Prot

This sequencing helps clarify which medication causes any side effects and allows your body to adapt to one hormonal change at a time